208 related articles for article (PubMed ID: 14741404)
1. Survival of motor neuron gene downregulation by RNAi: towards a cell culture model of spinal muscular atrophy.
Trülzsch B; Davies K; Wood M
Brain Res Mol Brain Res; 2004 Jan; 120(2):145-50. PubMed ID: 14741404
[TBL] [Abstract][Full Text] [Related]
2. Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?
Rossoll W; Kröning AK; Ohndorf UM; Steegborn C; Jablonka S; Sendtner M
Hum Mol Genet; 2002 Jan; 11(1):93-105. PubMed ID: 11773003
[TBL] [Abstract][Full Text] [Related]
3. Histologic and transcriptional assessment of a mild SMA model.
Balabanian S; Gendron NH; MacKenzie AE
Neurol Res; 2007 Jul; 29(5):413-24. PubMed ID: 17535551
[TBL] [Abstract][Full Text] [Related]
4. A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy.
Monani UR; Pastore MT; Gavrilina TO; Jablonka S; Le TT; Andreassi C; DiCocco JM; Lorson C; Androphy EJ; Sendtner M; Podell M; Burghes AH
J Cell Biol; 2003 Jan; 160(1):41-52. PubMed ID: 12515823
[TBL] [Abstract][Full Text] [Related]
5. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.
Monani UR; Sendtner M; Coovert DD; Parsons DW; Andreassi C; Le TT; Jablonka S; Schrank B; Rossoll W; Prior TW; Morris GE; Burghes AH
Hum Mol Genet; 2000 Feb; 9(3):333-9. PubMed ID: 10655541
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells.
Grzeschik SM; Ganta M; Prior TW; Heavlin WD; Wang CH
Ann Neurol; 2005 Aug; 58(2):194-202. PubMed ID: 16049920
[TBL] [Abstract][Full Text] [Related]
7. Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III.
Jablonka S; Schrank B; Kralewski M; Rossoll W; Sendtner M
Hum Mol Genet; 2000 Feb; 9(3):341-6. PubMed ID: 10655542
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit.
Anderson KN; Baban D; Oliver PL; Potter A; Davies KE
Neuromuscul Disord; 2004 Nov; 14(11):711-22. PubMed ID: 15482955
[TBL] [Abstract][Full Text] [Related]
9. Survival motor neuron protein regulates apoptosis in an in vitro model of spinal muscular atrophy.
Parker GC; Li X; Anguelov RA; Toth G; Cristescu A; Acsadi G
Neurotox Res; 2008 Jan; 13(1):39-48. PubMed ID: 18367439
[TBL] [Abstract][Full Text] [Related]
10. Co-regulation of survival of motor neuron (SMN) protein and its interactor SIP1 during development and in spinal muscular atrophy.
Jablonka S; Bandilla M; Wiese S; Bühler D; Wirth B; Sendtner M; Fischer U
Hum Mol Genet; 2001 Mar; 10(5):497-505. PubMed ID: 11181573
[TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular basis of spinal muscular atrophy.
Jablonka S; Sendtner M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):144-9. PubMed ID: 13129800
[TBL] [Abstract][Full Text] [Related]
12. On the possible role of muscle in the pathogenesis of spinal muscular atrophy.
Guettier-Sigrist S; Coupin G; Braun S; Rogovitz D; Courdier I; Warter JM; Poindron P
Fundam Clin Pharmacol; 2001 Feb; 15(1):31-40. PubMed ID: 11468011
[TBL] [Abstract][Full Text] [Related]
13. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
[TBL] [Abstract][Full Text] [Related]
14. Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect.
Gavrilina TO; McGovern VL; Workman E; Crawford TO; Gogliotti RG; DiDonato CJ; Monani UR; Morris GE; Burghes AH
Hum Mol Genet; 2008 Apr; 17(8):1063-75. PubMed ID: 18178576
[TBL] [Abstract][Full Text] [Related]
15. The survival motor neuron protein in spinal muscular atrophy.
Coovert DD; Le TT; McAndrew PE; Strasswimmer J; Crawford TO; Mendell JR; Coulson SE; Androphy EJ; Prior TW; Burghes AH
Hum Mol Genet; 1997 Aug; 6(8):1205-14. PubMed ID: 9259265
[TBL] [Abstract][Full Text] [Related]
16. Spinal muscular atrophy: the RNP connection.
Eggert C; Chari A; Laggerbauer B; Fischer U
Trends Mol Med; 2006 Mar; 12(3):113-21. PubMed ID: 16473550
[TBL] [Abstract][Full Text] [Related]
17. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
[TBL] [Abstract][Full Text] [Related]
18. Therapeutics development for spinal muscular atrophy.
Sumner CJ
NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261
[TBL] [Abstract][Full Text] [Related]
19. Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophy.
Brichta L; Garbes L; Jedrzejowska M; Grellscheid SN; Holker I; Zimmermann K; Wirth B
Hum Genet; 2008 Mar; 123(2):141-53. PubMed ID: 18172693
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in cellulo evidences for association of the survival of motor neuron complex with the fragile X mental retardation protein.
Piazzon N; Rage F; Schlotter F; Moine H; Branlant C; Massenet S
J Biol Chem; 2008 Feb; 283(9):5598-610. PubMed ID: 18093976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
